Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies.

CONCLUSION: Rapid onset of preventive effect on the first day after injection of galcanezumab was confirmed in both studies of episodic migraine. PMID: 31710104 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31710104?dopt=Abstract

Source: Headache - November 10, 2019 Category: Neurology Authors: Detke HC, Millen BA, Zhang Q, Samaan K, Ailani J, Dodick DW, Aurora SK Tags: Headache Source Type: research